<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="69650">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02199067</url>
  </required_header>
  <id_info>
    <org_study_id>PIAG1</org_study_id>
    <nct_id>NCT02199067</nct_id>
  </id_info>
  <brief_title>Measurement of Exhaled Propofol</brief_title>
  <acronym>PIAG1</acronym>
  <official_title>Measurement of Exhaled Propofol During a Total Intravenous Anesthesia With Propofol and Remifentanil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propofol is a common intravenous anaesthetic drug used for anaesthesia induction and for
      permanent infusion to maintain anaesthesia (total intravenous anaesthesia). Different to the
      volatile anaesthetics (feedback concentrations in exhaled breathing gas) piloting of an
      total intravenous anaesthesia with propofol is done only by experience of the anaesthetist
      or according to pharmacokinetic models. In this study we want to investigate if the exhaled
      fraction of propofol is a potential measurement parameter for piloting anaesthesia. Exhaled
      propofol will be measured with an electrochemical sensor developed by &quot;Drägerwerk AG &amp; Co.
      KGaA&quot;. Exhaled propofol levels will be compared with the corresponding arterial serum
      concentrations of propofol. Furthermore we investigate the correlation of exhaled propofol
      levels with the Bispectral Index (BIS).
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    technical difficulties of probe measurement
  </why_stopped>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>exhaled propofol levels in breathing gas</measure>
    <time_frame>continous recording during the whole anaesthesia (duration depents on surgery, between 2 and 12 hours)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>propofol concentration in arterial blood serum</measure>
    <time_frame>samples taken during anaesthesia (13 blood samples), duration of anaesthesia depends on surgery, 2 to 12 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bispectral Index (BIS)</measure>
    <time_frame>continous recording during the whole anaesthesia (duration depents on surgery, between 2 and 12 hours)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Anaesthesia With Propofol</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      arterial blood samples (serum)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  patients undergoing elective surgery

          -  total intravenous anaesthesia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA (American Society of Anaesthesiologists) classification I &amp; II

          -  Body-Mass-Index &lt; 35

          -  elective surgery with the necessity of an arterial catheter

        Exclusion Criteria:

          -  chronic obstructive lung disease

          -  bronchial asthma

          -  smokers with more than 5 packyears

          -  peripheral artery occlusive disease

          -  diabetes mellitus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 23, 2017</lastchanged_date>
  <firstreceived_date>July 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Tino Münster</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
